Reporting preclinical gene therapy studies in the field of Niemann-Pick type C disease according to the ARRIVE guidelines
Abstract The lack of essential information when reporting animal studies causing lower reproducibility has been stressed for decades. The ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines were first published in 2010, to improve reporting of animal research, making in vivo studie...
Saved in:
| Main Authors: | Charlotte Laurfelt Munch Rasmussen, Annette Burkhart, Torben Moos, Louiza Bohn Thomsen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Orphanet Journal of Rare Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13023-024-03479-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Reporting preclinical gene therapy studies in the field of Niemann-Pick type C disease according to the ARRIVE guidelines
by: Charlotte Laurfelt Munch Rasmussen, et al.
Published: (2025-06-01) -
Niemann-Pick disease type C: a case series of Brazilian patients
by: Paulo José Lorenzoni, et al.
Published: (2014-03-01) -
Clinical, genotypic, and neuropsychological profile in a series of patients with Niemann-Pick type C disease
by: Rita dos Santos Mendes, et al.
Published: (2025-02-01) -
Bone marrow involvement of a patient with Niemann-Pick disease concomitant with Kartagener’s syndrome: Report of a rare case
by: Muzaffer Keklik, et al.
Published: (2014-08-01) -
Practical recommendations for diagnosis, management, and follow-up of Niemann-Pick type-C disease patients: a Brazilian perspective
by: Dafne Dain Gandelman Horovitz, et al.
Published: (2025-03-01)